{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T04:47:35Z","timestamp":1791607655699,"version":"4.3.4"},"reference-count":40,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JPR"],"DOI":"10.2147\/jpr.s322292","type":"journal-article","created":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T02:50:50Z","timestamp":1629341450000},"page":"2529-2542","source":"Crossref","is-referenced-by-count":19,"title":["A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy, Tolerability, and Safety of Celecoxib Oral Solution (ELYXYB) in Acute Treatment of Episodic Migraine with or without Aura"],"prefix":"10.2147","volume":"Volume 14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2652-2897","authenticated-orcid":true,"given":"Richard B","family":"Lipton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5387-720X","authenticated-orcid":true,"given":"Sagar","family":"Munjal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stewart J","family":"Tepper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Iaconangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2021,8]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/head.12499","volume":"55","author":"Marmura","year":"2015","journal-title":"Headache"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/head.13281","volume":"58","author":"Burch","year":"2018","journal-title":"Headache"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","volume":"68","author":"Lipton","year":"2007","journal-title":"Neurology"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1212\/01.wnl.0000225186.76323.69","volume":"67","author":"Bigal","year":"2006","journal-title":"Neurology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1526-4610.2012.02292.x","volume":"53","author":"Lipton","year":"2013","journal-title":"Headache"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/head.13708","volume":"60","author":"Munjal","year":"2020","journal-title":"Headache"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/ana.21211","volume":"63","author":"Lipton","year":"2008","journal-title":"Ann Neurol"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"American Headache Society. The American Headache Society position statement on integrating new migraine treatments into clinical practice. Headache. 2019;59(1):1\u201318.","DOI":"10.1111\/head.13496"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"2599","DOI":"10.1001\/jama.284.20.2599","volume":"284","author":"Lipton","year":"2000","journal-title":"JAMA"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"S21","DOI":"10.1111\/j.1526-4610.2008.01336.x","volume":"49","author":"Bigal","year":"2009","journal-title":"Headache"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/BF00193709","volume":"47","author":"Lacey","year":"1995","journal-title":"Eur J Clin Pharmacol"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2165\/00003495-200060060-00003","volume":"60","author":"Tfelt-Hansen","year":"2000","journal-title":"Drugs"},{"key":"ref13","first-page":"147","volume":"11","author":"Tepper","year":"2018","journal-title":"Med Devices (Auckl)"},{"key":"ref14","first-page":"27","volume":"6","author":"Moore","year":"2012","journal-title":"Patient Prefer Adherence"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1046\/j.1468-2982.1998.1808532.x","volume":"18","author":"Tfelt-Hansen","year":"1998","journal-title":"Cephalalgia"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1111\/head.12233","volume":"53","author":"Loder","year":"2013","journal-title":"Headache"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1526-4610.2008.01217.x","volume":"48","author":"Bigal","year":"2008","journal-title":"Headache"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1526-4610.2011.02050.x","volume":"52","author":"Buse","year":"2012","journal-title":"Headache"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/head.12266","volume":"54","author":"Levin","year":"2014","journal-title":"Headache"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3122\/jabfm.2014.03.130290","volume":"27","author":"Paulozzi","year":"2014","journal-title":"J Am Board Fam Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.jpain.2010.02.007","volume":"11","author":"Gregorian","year":"2010","journal-title":"J Pain"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jns.2012.12.020","volume":"326","author":"Holland","year":"2013","journal-title":"J Neurol Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1097\/FPC.0b013e32834f94cb","volume":"22","author":"Gong","year":"2012","journal-title":"Pharmacogenet Genomics"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/WCO.0b013e328360864b","volume":"26","author":"Antonova","year":"2013","journal-title":"Curr Opin Neurol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1186\/ar1793","volume":"7","author":"Peura","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.amjmed.2017.06.028","volume":"130","author":"Solomon","year":"2017","journal-title":"Am J Med"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"R644","DOI":"10.1186\/ar1704","volume":"7","author":"Moore","year":"2005","journal-title":"Arthritis Res Ther"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1056\/NEJMoa1611593","volume":"375","author":"Nissen","year":"2016","journal-title":"N Engl J Med"},{"key":"ref29","first-page":"834","volume":"48","author":"Loo","year":"2007","journal-title":"Singapore Med J"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s40261-017-0548-6","volume":"37","author":"Pal","year":"2017","journal-title":"Clin Drug Investig"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2147\/JPR.S287571","volume":"14","author":"Lipton","year":"2021","journal-title":"J Pain Res"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/head.13663","volume":"60","author":"Lipton","year":"2020","journal-title":"Headache"},{"key":"ref33","unstructured":"Food and Drug Administration. FDA approves Elyxyb (celecoxib) oral solution for acute treatment of migraine with or without aura In adults. Drugs.com; 2020. Available from: https:\/\/www.drugs.com\/newdrugs\/fda-approves-elyxyb-celecoxib-oral-solution-acute-migraine-without-aura-adults-5223.html. Accessed August 22, 2020."},{"key":"ref34","unstructured":"U.S. Food and Drug Administration. Migraine: developing drugs for acute treatment. Guidance for Industry; 2018. Available from: https:\/\/www.fda.gov\/media\/89829\/download. Accessed August 20, 2020."},{"key":"ref35","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1468-2982.2007.01524.x","volume":"28","author":"Kimel","year":"2008","journal-title":"Cephalalgia"},{"key":"ref36","unstructured":"Imitrex (Sumatriptan Succinate Tablet) [Prescribing Information]. Research Triangle Park, NC: GlaxoSmithKline; 2017."},{"key":"ref37","volume-title":"Mixed Model Influence Diagnostics","year":"2005"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1177\/0003122409359166","volume":"75","author":"Van der Meer","year":"2010","journal-title":"ASR"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1586\/ern.10.8","volume":"10","author":"Speciali","year":"2010","journal-title":"Expert Rev Neurother"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/j.1468-2982.2004.00817.x","volume":"25","author":"Loder","year":"2005","journal-title":"Cephalalgia"}],"container-title":["Journal of Pain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=72780","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=72780","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,8,19]],"date-time":"2021-08-19T02:51:21Z","timestamp":1629341481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/a-multicenter-randomized-double-blind-placebo-controlled-study-of-the--peer-reviewed-fulltext-article-JPR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":40,"URL":"https:\/\/doi.org\/10.2147\/jpr.s322292","relation":{},"ISSN":["1178-7090"],"issn-type":[{"value":"1178-7090","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8]]}}}